Sort
78,016 grants matching “breast cancer”
Duluth Community Clinical Oncology Program
$798,586Daniel A Nikcevich · Duluth Clinic, Ltd. · U10 · FY2008 · CA
TrAstuzumab Cardiomyopathy Therapeutic Intervention with Carvedilol (TACTIC) Trial
$798,417Joerg Herrmann · Mayo Clinic Rochester · R01 · FY2023 · CA
Diffusion Weighted Breast MR Imaging for Screening Women with Dense Breasts
$798,404Alan I. Penn · Alan Penn And Associates, Inc. · R44 · FY2014 · CA
iDAPT: Implementation and Informatics - Developing Adaptable Processes and Technologies for Cancer Control
$798,375Kristie L Foley · Wake Forest University Health Sciences · P50 · FY2019 · CA
UIC CENTERS FOR POPULATION HEALTH AND HEALTH DISPARITIES
$798,291Elizabeth Ann Calhoun · University Of Illinois At Chicago · P50 · FY2014 · CA
Development of Natural Product Leads as Anticancer Therapeutics
$798,286John Beutler · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Biology of Mammary Gland Development and Tumorigenesis
$798,215Gilbert Smith · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Development of a precision medicine platform for circadian based therapeutics in pancreatic cancer
$798,207Faraz Bishehsari · University Of Texas Hlth Sci Ctr Houston · R01 · FY2024 · CA
Assessment of ultrasound-facilitated neurotherapeutics in Alzheimer's disease
$798,155Elisa E Konofagou · Columbia University Health Sciences · R56 · FY2023 · AG
Breast and Ovary Cancer Clinical Validation Center
$798,082Christopher I Li · Fred Hutchinson Cancer Research Center · U01 · FY2011 · CA
Identifying Diagnostic Markers for Cervical, Breast, and Prostate Cancer
$798,080Thomas Ried · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Longitudinal models of breast cancer for studying mechanisms of therapy response and resistance
$798,057Bryan E. Welm · University Of Utah · U01 · FY2019 · CA
Immunosurveillance of breast glands with oncogenic germline mutations
$797,986Shadmehr Demehri · Massachusetts General Hospital · UG3 · FY2024 · CA
Immunosurveillance of breast glands with oncogenic germline mutations
$797,986Shadmehr Demehri · Massachusetts General Hospital · UG3 · FY2025 · CA
North Central Cancer Treatment Group
$797,973Jan C Buckner · Mayo Clinic Rochester · U10 · FY2009 · CA
Definition of the Microenvironment in Breast Cancer
$797,865Mina J Bissell · University Of Calif-Lawrenc Berkeley Lab · R01 · FY2020 · CA
Engineering Multifunctional Nanoparticles
$797,711Sangeeta N. Bhatia · Massachusetts Institute Of Technology · R01 · FY2010 · CA
Mayo Clinic Breast Cancer SPORE
$797,371Matthew Philip Goetz · Mayo Clinic Rochester · P50 · FY2021 · CA
Prospective Trial of a Linguistically and Culturally Appropriate Mainstreaming Model for Hereditary Cancer Multigene Panel Testing Among Diverse Cancer Patients
$797,354Jada Gabrielle Hamilton · Sloan-Kettering Inst Can Research · U01 · FY2020 · CA
ATP-dependent and independent mechanisms of regulating chromatin states
$797,138Geeta Narlikar · University Of California, San Francisco · R35 · FY2021 · GM
ATP-dependent and independent mechanisms of regulating chromatin states
$797,138Geeta Narlikar · University Of California, San Francisco · R35 · FY2022 · GM
Molecular signatures for liver cancer diagnosis and treatment stratification
$797,101Xin Wang · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
Breast cancer prognostic factors/pathobiology
$797,054Kathleen E Malone · Fred Hutchinson Cancer Research Center · R01 · FY2008 · CA
A Personalized Digital Intervention Program to Reduce Exposure to Endocrine Disrupting Chemicals among a Child-Bearing Age Cohort
$796,881Jenna Hua · Million Marker Wellness Inc. · R44 · FY2024 · ES
Elucidating the molecular and contextual basis for IDLE ultralow risk lesions and the tumor immune microenvironment of high risk in situ and invasive breast cancers
$796,788Laura J Esserman · University Of California, San Francisco · U01 · FY2015 · CA